EAM
Exane Asset Management’s CytomX Therapeutics CTMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-30,568
| Closed | -$200K | – | 20 |
|
|
2020
Q4 | $200K | Sell |
30,568
-33,252
| -52% | -$218K | 0.14% | 18 |
|
|
2020
Q3 | $424K | Sell |
63,820
-24,056
| -27% | -$160K | 0.28% | 19 |
|
|
2020
Q2 | $732K | Hold |
87,876
| – | – | 0.75% | 16 |
|
|
2020
Q1 | $674K | Hold |
87,876
| – | – | 1.31% | 10 |
|
|
2019
Q4 | $730K | Buy |
87,876
+33,811
| +63% | +$281K | 0.9% | 24 |
|
|
2019
Q3 | $399K | Sell |
54,065
-52,935
| -49% | -$391K | 0.31% | 23 |
|
|
2019
Q2 | $1.2M | Buy |
107,000
+7,000
| +7% | +$78.5K | 0.53% | 44 |
|
|
2019
Q1 | $1.08M | Buy |
100,000
+50,000
| +100% | +$538K | 0.52% | 37 |
|
|
2018
Q4 | $755K | Buy |
50,000
+22,100
| +79% | +$334K | 0.44% | 34 |
|
|
2018
Q3 | $516K | Buy |
27,900
+5,700
| +26% | +$105K | 0.16% | 52 |
|
|
2018
Q2 | $507K | Buy |
22,200
+4,200
| +23% | +$96K | 0.22% | 45 |
|
|
2018
Q1 | $512K | Buy |
18,000
+9,000
| +100% | +$256K | 0.15% | 50 |
|
|
2017
Q4 | $190K | Buy |
+9,000
| New | +$190K | 0.06% | 46 |
|